| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/24/1996 | EP0722434A1 Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation |
| 07/24/1996 | EP0722334A1 Therapeutic treatment for inhibiting blood vessel blockage using a polypeptide |
| 07/24/1996 | EP0722326A1 Highly sulfated maltooligosaccharides with heparin-like properties |
| 07/24/1996 | CN1127508A Fused benzazepine derivative and pharmaceutical composition containing the same |
| 07/24/1996 | CN1127502A Benzene derivative useful for ischemic diseases |
| 07/24/1996 | CN1127252A Branched-amino-sbustituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them |
| 07/24/1996 | CN1127114A Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments |
| 07/24/1996 | CN1032360C Preparing process of tetrahydroberberine type quanternary ammonium compound |
| 07/24/1996 | CA2167763A1 Mercaptoalkyldipeptide derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 07/23/1996 | US5538992 Potentiation of drug response |
| 07/23/1996 | US5538960 Hydrazono-5β, 14β-androstane derivatives active on the cardiovascular system, and pharmaceutical compositions containing same |
| 07/23/1996 | US5538950 Endothelin antagonists and their preparation |
| 07/23/1996 | CA2054188C Inclusion complexes of n-ethoxycarbonyl-3-morpholino- sydnonimine or salts formed with cyclodextrin-derivatives, preparation thereof and pharmaceutical compositions containing thesame |
| 07/23/1996 | CA1338484C 2,3-disubstituted isoxazolidines, a process for their preparation, agents containing them, and their use |
| 07/23/1996 | CA1338475C Stereospecific process for the preparation of furo ¬3,4-c| pyridine enantiomers and compounds thus obtained |
| 07/20/1996 | CA2167353A1 2,9-disubstituted purin-6-ones |
| 07/20/1996 | CA2167349A1 9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones |
| 07/20/1996 | CA2167345A1 2,8-disubstituted quinazolinones |
| 07/18/1996 | WO1996021674A1 Novel peptides, their production and use |
| 07/18/1996 | WO1996021656A1 Estrogen agonists/antagonists |
| 07/18/1996 | WO1996021655A2 Substituted oxazolidine calpain and/or cathepsin b inhibitors |
| 07/18/1996 | WO1996021654A1 Novel compounds |
| 07/18/1996 | WO1996021643A1 Antiarrhythmic (s)-enantiomers of methanesulfonamides |
| 07/18/1996 | WO1996021641A1 Enantiomers of 1-(3,4-dichlorobenzyl)-2-methylaminoindane |
| 07/18/1996 | WO1996021638A1 Novel compounds |
| 07/18/1996 | WO1996021452A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | WO1996001253A3 PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption |
| 07/18/1996 | DE19500990A1 Neues Peptid, seine Herstellung und Verwendung New peptide, its preparation and use |
| 07/18/1996 | CA2210322A1 Novel compounds |
| 07/18/1996 | CA2209938A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | CA2209496A1 Novel peptides, their production and use |
| 07/17/1996 | EP0721983A1 Methods of producing biologically active peptide dimers |
| 07/17/1996 | EP0721950A2 Cardioactive 3-alkoxycarbonyl-thiadiazinones |
| 07/17/1996 | EP0721947A1 Alkyl(hetero)cyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/17/1996 | EP0721938A1 Alkyl(hetero)cyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/17/1996 | EP0721778A2 NK-1 receptor antagonists for the treatment of neuronal injury and stroke |
| 07/17/1996 | EP0721459A1 Novel oligosaccharide-containing 14-aminosteroid compounds and novel diastereoselective aminosteroid process chemistry |
| 07/17/1996 | EP0721455A1 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors |
| 07/17/1996 | EP0721454A1 New pyrazole derivatives as angiotensin ii antagonist |
| 07/17/1996 | EP0609289B1 Imidazole derivatives and pharmaceutical compositions containing the same |
| 07/17/1996 | EP0593450B1 COMPOSITIONS comprising omega conotoxin peptide derivatives and their use FOR TREATING ISCHEMIA-RELATED NEURONAL DAMAGE |
| 07/17/1996 | EP0549704B1 Complexes of nitric oxide with polyamines |
| 07/17/1996 | CN1126994A Novel (1-heteroazolyl-1-heterocyclyl) alkane derivatives and their use as neuroprotective agents |
| 07/17/1996 | CN1126991A Novel (1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl) methylamine derivatives |
| 07/17/1996 | CN1126990A Novel (1-phenyl-1-heterocyclyl) alkane derivatives and their use as neuroprotective agents |
| 07/17/1996 | CN1126759A Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide |
| 07/17/1996 | CN1126727A 11,21-bisphenyl-19-norpregnane derivatives |
| 07/17/1996 | CN1126720A Heterocyclo-benzoylguanidin |
| 07/17/1996 | CN1032309C 吲哚衍生物 Indole derivatives |
| 07/17/1996 | CN1032308C Process for preparing optically active 2-oxoimidazolidine derivatives |
| 07/16/1996 | US5537534 Disk array having redundant storage and methods for incrementally generating redundancy as data is written to the disk array |
| 07/16/1996 | US5536832 N-acyl-2,3-benzodiazepine derivatives pharmaceutical compositions containing them and process for preparing same |
| 07/16/1996 | US5536744 Dilation of blood vessels |
| 07/16/1996 | US5536736 Triazolyl-phenoxyacetic acid compounds which have useful pharmaceutical utility |
| 07/16/1996 | US5536721 Thieno[2,3-b-indole derivatives and their use for treating central nervous system diseases related to the metabotropic glutamate receptor system |
| 07/16/1996 | US5536718 Tricyclic benzazepine vasopressin antagonists |
| 07/16/1996 | CA2014520C Hexitol derivatives |
| 07/12/1996 | CA2166854A1 3-alkoxycarbonyl-thiadiazinones |
| 07/11/1996 | WO1996020936A1 Novel thiazolidin-4-one derivatives |
| 07/11/1996 | WO1996020930A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity |
| 07/11/1996 | WO1996020926A1 Substituted imides as tnf inhibitors |
| 07/11/1996 | WO1996020914A1 Tricyclic retinoids, methods for their production and use |
| 07/11/1996 | WO1996020718A2 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin |
| 07/11/1996 | WO1996020704A1 Treating disorders characterised by excessive cell proliferation with sclareolide |
| 07/11/1996 | WO1996020698A2 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | WO1996020690A2 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds |
| 07/11/1996 | WO1996015128A3 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION |
| 07/11/1996 | CA2209619A1 Thrombolytic agents |
| 07/11/1996 | CA2209276A1 Treating disorders characterised by excessive cell proliferation with sclareolide |
| 07/11/1996 | CA2209134A1 Tricyclic retinoids, methods for their production and use |
| 07/11/1996 | CA2208844A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity |
| 07/11/1996 | CA2207961A1 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | CA2184174A1 Novel thiazolidin-4-one derivatives |
| 07/10/1996 | EP0720855A2 Composition for the treatment of hypertension comprising non halide salts of potassium |
| 07/10/1996 | EP0720617A1 Novel urethane-containing aminosteroid compounds |
| 07/10/1996 | EP0720616A1 Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds |
| 07/10/1996 | EP0720599A1 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 07/10/1996 | EP0720598A1 Phenoxyphenyl cyclopentenyl hydroxyureas |
| 07/10/1996 | EP0720597A1 Triaryl-ethylene derivatives for use in therapy |
| 07/10/1996 | EP0619818B1 Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring |
| 07/10/1996 | CN1126472A 5-HT4 receptor antagonists |
| 07/10/1996 | CN1126466A Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system |
| 07/10/1996 | CN1126434A Therapeutic substituted guanidines |
| 07/10/1996 | CN1126203A Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
| 07/10/1996 | CN1126202A Heterocyclyloxy benzoylguanidin |
| 07/10/1996 | CN1126201A Fullfluoralkyl-substituted bezoylguanidine, preparation, parmaceuticle use of same and pharmaceutical containing same |
| 07/09/1996 | US5534529 Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses |
| 07/09/1996 | US5534526 Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome |
| 07/09/1996 | US5534509 Pharmaceutical composition regulating function of a living body |
| 07/09/1996 | US5534503 2'-O, N6 -disubstituted and 2'-O, N6, 2-trisubstituted adenosines and their medicinal uses |
| 07/09/1996 | CA1338453C Purified protein having angiogenic activity and methods of preparation |
| 07/04/1996 | WO1996020279A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases |
| 07/04/1996 | WO1996020215A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | WO1996020184A1 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors |
| 07/04/1996 | WO1996020172A1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED β-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |
| 07/04/1996 | WO1996020159A1 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds |
| 07/04/1996 | WO1996019991A1 Benzimidazoles as inhibitors of calcitriol metabolism |
| 07/04/1996 | WO1996019988A1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds |
| 07/04/1996 | WO1996019987A1 Use of nebivolol as an anti-atherogenic |
| 07/04/1996 | DE4447599A1 Use of racemic or enantiomeric alpha liponic acid and derivs |